Early antibiotic treatment of pseudomonas aeruginosa colonisation in cystic fibrosis: a critical review of the literature (Q35683898)

9 August 2017

1 reference

title

Early antibiotic treatment of pseudomonas aeruginosa colonisation in cystic fibrosis: a critical review of the literature (English)

1 reference

9 August 2017

0 references

0 references

Pseudomonas aeruginosa

1 reference

Federico Marchetti

1

1 reference

9 August 2017

Luisella Giglio

2

1 reference

9 August 2017

Manila Candusso

3

1 reference

9 August 2017

Dino Faraguna

4

1 reference

9 August 2017

Baroukh M Assael

5

1 reference

9 August 2017

language of work or name

1 reference

5 March 2004

1 reference

European Journal of Clinical Pharmacology

9 August 2017

1 reference

9 August 2017

60

1 reference

9 August 2017

67-74

1 reference

9 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-004-0735-2

9 August 2017

0 references

cites work

Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.

1 reference

12 December 2020

Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis

1 reference

12 December 2020

Aerosol therapy in cystic fibrosis: a survey of 54 CF centers

1 reference

12 December 2020

Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa

1 reference

12 December 2020

Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis.

1 reference

12 December 2020

Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis

1 reference

12 December 2020

The changing epidemiology of cystic fibrosis

1 reference

12 December 2020

The preservation of function: treatment of new acquisition of a pathogen

1 reference

12 December 2020

Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis

1 reference

12 December 2020

Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis

1 reference

12 December 2020

Treatment of pseudomonas aeruginosa colonisation in cystic fibrosis

1 reference

12 December 2020

Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

1 reference

12 December 2020

Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis.

1 reference

12 December 2020

Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada

1 reference

12 December 2020

Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis

1 reference

12 December 2020

Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference

1 reference

12 December 2020

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

1 reference

12 December 2020

The role of Pseudomonas aeruginosa in the pathogenesis of lung disease in cystic fibrosis: more questions than answers

1 reference

12 December 2020

Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis

1 reference

12 December 2020

Bacterial infections and inflammation in the lungs of cystic fibrosis patients

1 reference

12 December 2020

Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition

1 reference

12 December 2020

Randomized controlled trials in cystic fibrosis (1966-1997) categorized by time, design, and intervention

1 reference

12 December 2020

1 reference

12 December 2020

Evidence for using nebulised antibiotics in cystic fibrosis

1 reference

12 December 2020

Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis

1 reference

12 December 2020

Compliance with treatment in adult patients with cystic fibrosis

1 reference

12 December 2020

The age at onset of chronic Pseudomonas aeruginosa colonization in cystic fibrosis--prognostic significance

1 reference

12 December 2020

Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization

1 reference

12 December 2020

Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis

1 reference

12 December 2020

Early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis

1 reference

12 December 2020

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

1 reference

12 December 2020

Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients

1 reference

12 December 2020

10.1007/S00228-004-0735-2

Identifiers

DOI

1 reference

9 August 2017

1 reference